Form 8-K - Current report:
SEC Accession No. 0001140361-24-050057
Filing Date
2024-12-20
Accepted
2024-12-20 14:28:21
Documents
15
Period of Report
2024-12-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20040455_8k.htm   iXBRL 8-K 27217
2 EXHIBIT 99.1 ef20040455_ex99-1.htm EX-99.1 25654
6 image00001.jpg GRAPHIC 2479
  Complete submission text file 0001140361-24-050057.txt   199465

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20241219.xsd EX-101.SCH 3974
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20241219_lab.xml EX-101.LAB 21967
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20241219_pre.xml EX-101.PRE 16039
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20040455_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 241567361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)